
    
      To explore the safety, tolerance and pharmacokinetic of KPCXM18 for injection in healthy
      subjects by intravenous administration of different doses in single and multiple
      administration safety, tolerance and pharmacokinetic tests, and to obtain the safe dose range
      of the test drugs, thus providing dose design basis for phase II clinical trials.
    
  